ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
83,11
-0,02%
Bitcoin
63 991,14
-0,01%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Entrada Therapeutics Inc (TRDA)

  7. Entrada Therapeutics Inc (TRDA) Actualités

TRDA Entrada Therapeutics Inc

13,16
-0,40 (-2,95%)
04 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Entrada Therapeutics Inc TRDA NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
-0,40 -2,95% 13,16 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
13,70 12,92 13,91 13,16 13,56
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
13/3/202412:00GLOBEEntrada Therapeutics Reports Fourth Quarter and Full Year..
08/3/202422:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202422:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202422:22EDGAR2Form 144 - Report of proposed sale of securities
06/3/202422:22EDGAR2Form 144 - Report of proposed sale of securities
06/3/202401:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202401:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202401:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202413:00GLOBEEntrada Therapeutics to Present at Upcoming Investor..
03/1/202413:16EDGAR2Form 8-K - Current report
03/1/202413:00GLOBEEntrada Therapeutics Promotes Nathan J. Dowden to President
26/12/202322:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/12/202322:26EDGAR2Form 144 - Report of proposed sale of securities
06/12/202313:00EDGAR2Form 8-K - Current report
22/11/202317:56DJNEntrada Therapeutics Shares Tumble 27% After FDA Keeps..
22/11/202313:54DJNEntrada: FDA Declines to Lift Hold on Duchenne Study
22/11/202313:35EDGAR2Form 8-K - Current report
22/11/202313:00GLOBEEntrada Therapeutics Announces Updates on ENTR-601-44 in..
07/11/202313:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202313:08EDGAR2Form 8-K - Current report
07/11/202313:00GLOBEEntrada Therapeutics Reports Third Quarter 2023 Financial..
01/11/202312:01EDGAR2Form 8-K - Current report
12/10/202313:00GLOBEEntrada Therapeutics to Present at Upcoming Investor..
29/9/202322:39EDGAR2Form 8-K - Current report
29/9/202322:35EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
21/9/202313:09EDGAR2Form 8-K - Current report
21/9/202313:00GLOBEEntrada Therapeutics Announces First Participant Dosed in..
07/9/202313:00GLOBEEntrada Therapeutics Awards Funding to Non-Profit..
06/9/202323:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/9/202323:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/9/202323:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/9/202323:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/9/202322:09EDGAR2Form 144 - Report of proposed sale of securities
06/9/202322:09EDGAR2Form 144 - Report of proposed sale of securities
06/9/202322:08EDGAR2Form 144 - Report of proposed sale of securities
05/9/202322:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/9/202322:29EDGAR2Form 3 - Initial statement of beneficial ownership of..
29/8/202313:00GLOBEEntrada Therapeutics to Present at Upcoming Investor..
10/8/202313:09EDGAR2Form 8-K - Current report
10/8/202313:00GLOBEEntrada Therapeutics Appoints Gina Chapman to its Board of..
08/8/202313:25EDGAR2Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]:..
08/8/202313:23EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
08/8/202313:14EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202313:07EDGAR2Form 8-K - Current report
08/8/202313:00GLOBEEntrada Therapeutics Reports Second Quarter 2023 Financial..
04/8/202322:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/8/202322:10EDGAR2Form 144 - Report of proposed sale of securities
01/8/202313:08EDGAR2Form 8-K - Current report
01/8/202313:00GLOBEEntrada Therapeutics Receives Authorization in the United..
12/7/202322:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Dernières Valeurs Consultées

NASDAQ
TRDA
Entrada Therapeutics
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés